| Name | Title | Contact Details |
|---|
TranZfinity is providing a way for bank card issuers, mobile network operators, mobile handset manufacturers, transportation systems, merchants and advertisers leap from pilots into broader commercial rollouts.
Interested in working for Parkwood Behavioral Health System? You can view our open positions here https://jobs.uhsinc.com/parkwood-behavioral-health-system. Parkwood Behavioral Health System provides behavioral health and chemical dependency services to the Mid-South region, including individuals from DeSoto County in MS and Memphis, TN since 1987. We are located in DeSoto County, in the uppermost northwest corner of Mississippi and approximately 7 miles south of Memphis. As treatment options and patient care innovations have continued to become available we to strive to provide the highest level of safety and quality care for our patients. At Parkwood, our caring staff focuses on providing compassionate care to meet the needs of individuals, families and communities. We offer a full continuum of care that provides treatment options to meet the individual needs of adults, adolescents and children. Parkwood Behavioral Health System includes a 148-bed inpatient acute and residential care facility, as well as partial hospitalization and intensive outpatient programs.
City of St Peter is a Saint Peter, MN-based company in the Business Services sector.
Western States Environmental is a Medford, OR-based company in the Business Services sector.
AVITA Medical (NASDAQ: RCEL, ASX:AVH) is a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patients own skin to create Spray-On Skin™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm®, a Biosynthetic Wound Matrix, in the United States.